BofA Global Research raises AbbVie price target to $276 from $234
ABBV•Related News
Nasdaq trade halt continues SVA.O reason not available at 01:28 PM
SVA•
TFS Financial Chief Experience Officer Gavin B. Stefanski reports sale of 6,500 common shares worth $119,275
TFSL•
Fox Corp announces R$ 1 dividend per unit, payable Sept. 29
FOXA•
Jones Soda CFO Brian Meadows acquires 303,030 common shares for $99,999.9
JSDA•
Nasdaq Trade Halt <Huiz.O> Volatility Trading Pause at 02:37 PM
HUIZ•